hers and glp 1 Affordability Safety: How Hims & is Delivering a New GLP-1 Experience Through the Scale of Our Platform Hims & Hers swings to

Penn D, Dolderer M, Schmidt-Sommerfeld E

Table of Contents Incidence and Mechanisms Behind Gallbladder Events Patient-Level Risk Factors and Weight-Loss Magnitude Monitoring Strategies and Clinical Thresholds Counseling Patients While Preserving Metabolic Benefits Incidence and Mechanisms Behind Gallbladder Events Reports of gallbladder-related adverse events during GLP-1 therapy have emerged across randomized trials and real-world analyses

Snchez-Navarro, M., and Giralt, E., Peptide Shuttles for BloodBrain Barrier Drug Delivery, Pharmaceutics , 2022, 14 , 1874.

Inquire about their approach to testing (e.g., do they use urine mycotoxin panels or CIRS blood markers?), their preferred detoxification protocols, and their experience managing sensitive patients with comorbid conditions like MCAS and dysautonomia